The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.
about
c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XLPrognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.Spontaneous transformation of human granulosa cell tumours into an aggressive phenotype: a metastasis model cell lineApproaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometryEGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer.BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses.Antitumor and Apoptosis Induction Effects of Paeonol on Mice Bearing EMT6 Breast Carcinoma.Role of lifeguard β-isoform in the development of breast cancer.BAG-1 expression and function in human cancer.PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cellsThe essential role of evasion from cell death in cancer.Recent advances in p53 research and cancer treatmentTargeting signal transduction pathways in metastatic breast cancer: a comprehensive review.Isobavachalcone induces the apoptosis of gastric cancer cells via inhibition of the Akt and Erk pathways.Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients.Tumour microvessel density as predictor of chemotherapy response in breast cancer patients.Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patientsExpression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer"No Turning Bax" in the combined battle against prostate cancer:Prognostic value of the Fas/Fas ligand system in breast cancer.BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast.Nucleic acid clamp-mediated recognition and stabilization of the physiologically relevant MYC promoter G-quadruplex.Collagen gel droplet-embedded culture-drug sensitivity test and Ki67 expression in estrogen receptor-positive and HER2-negative breast cancer.Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer.Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Potential for modulation of the fas apoptotic pathway by epidermal growth factor in sarcomas.OSU-03012 suppresses GRP78/BiP expression that causes PERK-dependent increases in tumor cell killing.Prognostic value of Bcl-2 in breast cancer patients treated with neoadjuvant anthracycline based chemotherapy.Microarray-based gene expression analysis of hepatocellular carcinoma.Mechanisms of Drug Resistance in Veterinary Oncology- A Review with an Emphasis on Canine Lymphoma.
P2860
Q24653312-616BC4EB-FC86-44D8-97E6-182EB0BEF52BQ33281956-93979FB5-E10A-466A-8093-AE1BEF4C25B5Q33382297-404A6FB2-069A-4455-9E0D-A0F605E1EED0Q33418010-14D29C09-1D36-4B96-A82A-C3AB4E1365AAQ33793142-BC4BDC4A-E122-4CC7-875F-0A18F27B0634Q33920189-793C0458-E031-46E1-9F61-FBC339DCF1D1Q34039812-E293DCA4-D233-44AE-9044-0C946B29A870Q34105179-D5B2FF37-5640-4E09-94AB-03B0A3C9EFAFQ34954775-24E4CF9D-0EBB-439F-B103-053772D034EBQ35068026-4E92D97D-0F2A-4984-AC6B-630CEE27C6C3Q35083049-C2981ADE-2C78-4318-8D5A-CF84070D4F5AQ35099531-1ABB5F39-301D-400F-9BA0-5880B9C9418AQ35583942-CCAECD94-9D29-4507-AA02-AC97F5288887Q36524163-48225DD2-87D8-4D28-9DAA-E7A780FA65C4Q36609883-607A6ABD-8458-4FF0-AFE5-B11408B51052Q36644638-0B724F72-DB0B-43CE-8F86-83BF846FCEBCQ36673651-C0E1C260-49B1-422B-B512-F74DC94E73B0Q36678716-CC940099-93A1-480B-B77C-EBA2A1CAAE9CQ36733907-164EE0B8-5A25-4EFF-9AFE-E680D29AD0BEQ36936804-40475AD7-9426-442D-8575-0C2007C7875DQ37080948-EBAAC3B8-2D0D-490A-8685-063FEDF2DCA0Q37507524-DACBF94E-0ADF-4DE6-94EE-B23BFFC040D5Q37641078-28419E2F-83E5-4577-86CD-74F29842CE68Q37716586-5DF64D42-2EAF-4574-880A-370E12E4D34BQ38720813-33A320E1-D3B2-460A-8C47-CD82C145C64CQ38909468-144E9ACA-3834-4B75-8031-1551AA1E630FQ39392716-18FA74C1-86BB-4A2A-84DE-775166CB0B4FQ41129712-F1F89719-6FB6-4ED0-AE7C-7BAC24DEC9E7Q42438612-B9141628-2C3B-4D68-82B3-C8307EC211E2Q43185759-DA057509-FFEA-4729-8CD2-D01FA99C9EF1
P2860
The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
The predictive value of bcl-2, ...... nse in advanced breast cancer.
@en
The predictive value of bcl-2, ...... nse in advanced breast cancer.
@nl
type
label
The predictive value of bcl-2, ...... nse in advanced breast cancer.
@en
The predictive value of bcl-2, ...... nse in advanced breast cancer.
@nl
prefLabel
The predictive value of bcl-2, ...... nse in advanced breast cancer.
@en
The predictive value of bcl-2, ...... nse in advanced breast cancer.
@nl
P2093
P1476
The predictive value of bcl-2, ...... onse in advanced breast cancer
@en
P2093
Björn Ostenstadt
Carl Blomqvist
Eero Saksela
Ingvil Mjaaland
Johanna Sjöström
John C Reed
Kristina von Boguslawski
Nils-Olof Bengtsson
Shinichi Takayama
P304
P407
P577
2002-03-01T00:00:00Z